
|Articles|November 1, 2004
Investigational antimicrobial in development for acne
XMP.629 belongs to the BPI family of compounds ... it is able to kill gram-negative bacteria by selectively altering their outer membrane permeability.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
3
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
4
Health Canada Grants Priority Review to Birch Triterpenes for EB
5














